SCHEMBL22889233

SCHEMBL22889233

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5ccc6ccccc6c5)c5ccccc45)nc(-c4cccc5c4oc4ccccc45)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
GGPS1 O95749 1/20 0.38
PRKDC P78527 4/20 0.37
PLA2G2A P14555 2/20 0.36
PLA2G4A P47712 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 3/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889007 0.98 ALOX5 (0.47) ALOX5GGPS1PRKDCPLA2G2APLA2G4A
SCHEMBL22889298 0.98 ALOX5 (0.44) ALOX5GGPS1PRKDCPLA2G2APLA2G4A
SCHEMBL22889231 0.98 ALOX5 (0.47) ALOX5GGPS1PRKDCPLA2G2APLA2G4A
SCHEMBL26251941 0.96 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2ALDH1A1
SCHEMBL22888999 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2ALDH1A1
SCHEMBL22889392 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPLA2G2APLA2G4A
SCHEMBL22889009 0.95 ALOX5 (0.44) ALOX5GGPS1PRKDCALDH1A1KDM4E
SCHEMBL22888885 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2ALDH1A1
SCHEMBL22889277 0.95 ALOX5 (0.44) ALOX5GGPS1PRKDCALDH1A1KDM4E
SCHEMBL22889401 0.95 ALOX5 (0.46) ALOX5GGPS1PRKDCPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885PRKDC 4797/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885PRKDC 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.